{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T18:57:19Z","timestamp":1774119439309,"version":"3.50.1"},"reference-count":23,"publisher":"Japanese Society of Internal Medicine","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2024,4,1]]},"DOI":"10.2169\/internalmedicine.1946-23","type":"journal-article","created":{"date-parts":[[2023,7,25]],"date-time":"2023-07-25T22:11:16Z","timestamp":1690323076000},"page":"919-927","source":"Crossref","is-referenced-by-count":7,"title":["Antiemetic Effect of Rikkunshito, a Japanese Kampo Herbal Medicine, on Cisplatin-induced Nausea and Vomiting: A Nationwide Database Study in Japan"],"prefix":"10.2169","volume":"63","author":[{"given":"Taisuke","family":"Jo","sequence":"first","affiliation":[{"name":"Department of Health Services Research, the University of Tokyo, Japan"},{"name":"Department of Respiratory Medicine, the University of Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisuke","family":"Shigemi","sequence":"additional","affiliation":[{"name":"Department of Clinical Epidemiology and Health Economics, School of Public Health, the University of Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takaaki","family":"Konishi","sequence":"additional","affiliation":[{"name":"Department of Clinical Epidemiology and Health Economics, School of Public Health, the University of Tokyo, Japan"},{"name":"Department of Breast and Endocrine Surgery, Graduate School of Medicine, the University of Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hayato","family":"Yamana","sequence":"additional","affiliation":[{"name":"Department of Clinical Epidemiology and Health Economics, School of Public Health, the University of Tokyo, Japan"},{"name":"Data Science Center, Jichi Medical University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuaki","family":"Michihata","sequence":"additional","affiliation":[{"name":"Department of Health Services Research, the University of Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryosuke","family":"Kumazawa","sequence":"additional","affiliation":[{"name":"Department of Clinical Epidemiology and Health Economics, School of Public Health, the University of Tokyo, Japan"},{"name":"Center for Clinical Sciences, National Center for Global Health and Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Yokoyama","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, the University of Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirokazu","family":"Urushiyama","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, the University of Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroki","family":"Matsui","sequence":"additional","affiliation":[{"name":"Department of Clinical Epidemiology and Health Economics, School of Public Health, the University of Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiyohide","family":"Fushimi","sequence":"additional","affiliation":[{"name":"Department of Health Policy and Informatics, Tokyo Medical and Dental University Graduate School, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahide","family":"Nagase","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, the University of Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideo","family":"Yasunaga","sequence":"additional","affiliation":[{"name":"Department of Clinical Epidemiology and Health Economics, School of Public Health, the University of Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Ghosh S. Cisplatin: the first metal based anticancer drug. Bioorg Chem 88: 102925, 2019.","DOI":"10.1016\/j.bioorg.2019.102925"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Aogi K, Takeuchi H, Saeki T, et al. Optimizing antiemetic treatment for chemotherapy-induced nausea and vomiting in Japan: update summary of the 2015 Japan Society of Clinical Oncology clinical practice guidelines for antiemesis. Int J Clin Oncol 26: 1-17, 2021.","DOI":"10.1007\/s10147-020-01818-3"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Hesketh PJ, Kris MG, Basch E, et al. Antiemetics: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol 35: 3240-3261, 2017.","DOI":"10.1200\/JCO.2017.74.4789"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Roila F, Molassiotis A, Herrstedt J, et al. 2016 MASCC and ESMO guideline update for the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting and of nausea and vomiting in advanced cancer patients. Ann Oncol 27: v119-v133, 2016.","DOI":"10.1093\/annonc\/mdw270"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Piechotta V, Adams A, Haque M, et al. Antiemetics for adults for prevention of nausea and vomiting caused by moderately or highly emetogenic chemotherapy: a network meta-analysis. Cochrane Database Syst Rev 11: CD012775, 2021.","DOI":"10.1002\/14651858.CD012775.pub2"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Rapoport BL. Delayed chemotherapy-induced nausea and vomiting: pathogenesis, incidence, and current management. Front Pharmacol 8: 19, 2017.","DOI":"10.3389\/fphar.2017.00019"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Kusunoki H, Haruma K, Hata J, et al. Efficacy of Rikkunshito, a traditional Japanese medicine (Kampo), in treating functional dyspepsia. Intern Med 49: 2195-2202, 2010.","DOI":"10.2169\/internalmedicine.49.3803"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Inokuchi K, Masaoka T, Kanai T. Rikkunshito as a therapeautic agent for functional dyspepsia and its prokinetic and non-prokinetic effects. Front Pharmacol 12: 640576, 2021.","DOI":"10.3389\/fphar.2021.640576"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Seike J, Sawada T, Kawakita N, et al. A new candidate supporting drug, Rikkunshito, for the QOL in advanced esophageal cancer patients with chemotherapy using docetaxel\/5-FU\/CDDP. Int J Surg Oncol 2011: 715623, 2011.","DOI":"10.1155\/2011\/715623"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Ohno T, Yanai M, Ando H, et al. Rikkunshito, a traditional Japanese medicine, suppresses cisplatin-induced anorexia in humans. Clin Exp Gastroenterol 4: 291-296, 2011.","DOI":"10.2147\/CEG.S26297"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Harada T, Amano T, Ikari T, et al. Rikkunshito for preventing chemotherapy-induced nausea and vomiting in lung cancer patients: results from 2 prospective, randomized phase 2 trials. Front Pharmacol 8: 972, 2017.","DOI":"10.3389\/fphar.2017.00972"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Ohnishi S, Watari H, Kanno M, et al. Additive effect of Rikkunshito, an herbal medicine, on chemotherapy-induced nausea, vomiting, and anorexia in uterine cervical or corpus cancer patients treated with cisplatin and paclitaxel: results of a randomized phase II study (JORTC KMP-02). J Gynecol Oncol 28: e44, 2017.","DOI":"10.3802\/jgo.2017.28.e44"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Hamai Y, Yoshiya T, Hihara J, et al. Traditional Japanese herbal medicine Rikkunshito increases food intake and plasma acylated ghrelin levels in patients with esophageal cancer treated by cisplatin-based chemotherapy. J Thorac Dis 11: 2470-2478, 2019.","DOI":"10.21037\/jtd.2019.05.67"},{"key":"14","doi-asserted-by":"crossref","unstructured":"15. Yoshiya T, Mimae T, Ito M, et al. Prospective, randomized, cross-over pilot study of the effects of Rikkunshito, a Japanese traditional herbal medicine, on anorexia and plasma-acylated ghrelin levels in lung cancer patients undergoing cisplatin-based chemotherapy. Invest New Drugs 38: 485-492, 2020.","DOI":"10.1007\/s10637-019-00836-x"},{"key":"15","doi-asserted-by":"crossref","unstructured":"16. Yasunaga H. Real world data in Japan: chapter II the diagnosis procedure combination database. Ann Clin Epidemiol 1: 76-79, 2019.","DOI":"10.37737\/ace.1.3_76"},{"key":"16","doi-asserted-by":"crossref","unstructured":"17. Shigemi D, Morishima T, Yamana H, Yasunaga H, Miyashiro I. Validity of initial cancer diagnoses in the Diagnosis Procedure Combination data in Japan. Cancer Epidemiol 74: 102016, 2021.","DOI":"10.1016\/j.canep.2021.102016"},{"key":"17","doi-asserted-by":"crossref","unstructured":"18. Yamana H, Moriwaki M, Horiguchi H, Kodan M, Fushimi K, Yasunaga H. Validity of diagnoses, procedures, and laboratory data in Japanese administrative data. J Epidemiol 27: 476-482, 2017.","DOI":"10.1016\/j.je.2016.09.009"},{"key":"18","doi-asserted-by":"crossref","unstructured":"19. Yasunaga H. Introduction to applied statistics - chapter 1 propensity score analysis. Ann Clin Epidemiol 2: 33-37, 2020.","DOI":"10.37737\/ace.2.2_33"},{"key":"19","doi-asserted-by":"crossref","unstructured":"20. Belotti F, Deb P, Manning WG, Norton EC. Twopm: two-part models. Stata J 15: 3-20, 2015.","DOI":"10.1177\/1536867X1501500102"},{"key":"20","doi-asserted-by":"crossref","unstructured":"21. Arai T, Maejima Y, Muroya S, Yada T. Rikkunshito and isoliquiritigenin counteract 5-HT-induced 2C receptor-mediated activation of pro-opiomelanocortin neurons in the hypothalamic arcuate nucleus. Neuropeptides 47: 225-230, 2013.","DOI":"10.1016\/j.npep.2013.05.004"},{"key":"21","doi-asserted-by":"publisher","unstructured":"22. Takeda H, Sadakane C, Hattori T, et al. Rikkunshito, an herbal medicine, suppresses cisplatin-induced anorexia in rats via 5-HT2 receptor antagonism. Gastroenterology 134: 2004-2013, 2008.","DOI":"10.1053\/j.gastro.2008.02.078"},{"key":"22","doi-asserted-by":"crossref","unstructured":"23. Tominaga K, Kido T, Ochi M, et al. The traditional Japanese medicine Rikkunshito promotes gastric emptying via the antagonistic action of the 5-HT3 receptor pathway in rats. Evid Based Complement Alternat Med 2011: 248481, 2011.","DOI":"10.1093\/ecam\/nep173"},{"key":"23","doi-asserted-by":"crossref","unstructured":"24. Yamana H, Ono S, Michihata N, Jo T, Yasunaga H. Outpatient prescriptions of Kampo formulations in Japan. Intern Med 59: 2863-2869, 2020.","DOI":"10.2169\/internalmedicine.5012-20"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/63\/7\/63_1946-23\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,6]],"date-time":"2024-04-06T03:35:50Z","timestamp":1712374550000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/63\/7\/63_1946-23\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,1]]},"references-count":23,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.1946-23","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,1]]},"article-number":"1946-23"}}